Alliance Pharma, the specialty pharmaceutical company, today made its second acquisition in less than a week, snapping up pesticide-free head lice treatment Vamousse for $13m (£9.6m). The Chippenham-based firm, which buys underperforming drugs brands and realises their potential through investment, said the acquisition of Vamouse, like that of anaesthetic gel Ametop last week for...